A transparent marketplace for pet owners to compare veterinary costs, track medical history, and coordinate prescription fulfillment through trusted partners.

Is carboplatin a cure for cancer?

Carboplatin is rarely curative on its own; it is typically used to manage cancer, slow tumor progression, or improve the quality of life for pets with terminal diagnoses.

Will my pet lose their hair?

Most dogs and cats do not lose their fur like humans on chemotherapy, though breeds with continuously growing hair coats may experience thinning or slower regrowth.

How do I handle my pet's waste after treatment?

For 48 to 72 hours post-administration, you should use gloves to clean up urine and feces, as the drug and its metabolites can be excreted through these routes.

Can I give this drug at home?

No, carboplatin is a hazardous intravenous chemotherapy agent that must only be administered by trained staff in a clinical setting.

What should I do if my pet stops eating after the dose?

Mild gastrointestinal upset is common; however, if your pet refuses food for more than 24 hours or shows signs of severe lethargy, you must contact your veterinarian immediately.

Oncology

Carboplatin in Dogs & Cats

Generic: Carboplatin

Carboplatin is a potent, injectable platinum-based chemotherapy agent used in veterinary oncology to treat various solid tumors in dogs and cats.

This medication is intended for dogs and cats.

RxDogs & Cats

Overview

Carboplatin is a second-generation platinum-based antineoplastic agent widely utilized in veterinary medicine for the management of malignant tumors. It is structurally related to Cisplatin, but it has been modified to produce significantly fewer side effects, particularly regarding renal toxicity and emesis. Clinical oncology focuses on the administration of these agents to disrupt the replication of cancer cells, often as part of a multi-modal treatment plan. Veterinarians frequently combine carboplatin with other therapies such as Doxorubicin or Vinblastine to improve response rates in aggressive malignancies. In some treatment protocols, Prednisone (Oncology) may be co-administered to help manage inflammatory responses or provide palliative comfort during the course of chemotherapy. The primary clinical utility of carboplatin lies in its efficacy against solid tumors where surgical resection may be incomplete or impossible. Unlike Lomustine (CCNU), which is administered orally, carboplatin requires professional clinical oversight due to its specific intravenous delivery needs. Veterinary oncologists monitor patients closely to ensure that hematological parameters, such as white blood cell counts, remain within acceptable ranges throughout the therapy duration. Successful treatment outcomes depend on adherence to established dosing cycles, which allow normal cells time to recover between sessions of cytotoxic intervention.

What It Treats

Osteosarcoma: Often used as an adjuvant therapy following limb amputation to slow metastatic progression.
Carcinomas: Effective against various epithelial cancers, including transitional cell carcinoma of the bladder and nasal carcinomas.
Melanoma: Utilized in cases of malignant melanoma that are resistant to other forms of therapy.
Ovarian and Pulmonary Tumors: Employed to treat specific reproductive or thoracic malignancies where platinum sensitivity is anticipated.

How It Works

Carboplatin functions by entering the cancer cell and forming covalent bonds with the cell's DNA. This process creates intra-strand and inter-strand cross-links that distort the DNA structure, preventing the cell from replicating its genetic material during the S-phase of the cell cycle. When the cell cannot replicate its DNA, it triggers a programmed cell death mechanism known as apoptosis. Because cancer cells are inherently more rapidly dividing than healthy cells, they are more susceptible to this DNA damage, allowing the medication to target the tumor while sparing some of the host's healthy tissues. Unlike some agents like [Vincristine](/medications/vincristine-in-dogs-and-cats), which target the cell's structural skeleton, carboplatin targets the genetic blueprint directly.

Dosage

Dosage is strictly calculated based on the patient's body surface area (BSA) in square meters, not just weight. Owners must understand that chemotherapy doses are highly specialized; never adjust or skip a dose without direct authorization from your veterinary oncologist.

Administration

Carboplatin is administered exclusively by qualified veterinary professionals via a slow intravenous infusion. Because the drug is a vesicant and potentially hazardous, it must be handled according to strict oncology safety protocols using closed-system transfer devices where possible. The infusion is typically performed in a clinical setting over 15 to 30 minutes, often preceded and followed by intravenous fluid therapy to support renal health and ensure optimal drug distribution and elimination.

Storage

Vials should be stored at controlled room temperature, protected from light, and kept in their original packaging until use. Reconstituted solutions should be used immediately or stored under specific, validated stability conditions as outlined by the manufacturer; however, generally, they should not be kept for extended periods due to the risk of degradation and microbial contamination.

Contraindications

Carboplatin is strictly contraindicated in patients with pre-existing bone marrow suppression or severe renal impairment, as the kidneys are the primary route of excretion for the drug. It should also be avoided in pregnant or lactating animals due to the high risk of teratogenicity and fetal toxicity. Furthermore, any animal showing clinical signs of an active, severe infection should be stabilized prior to the initiation of platinum-based chemotherapy. Veterinarians must perform a complete blood count (CBC) prior to every treatment session; if neutrophil counts are below the threshold determined by the oncologist, the treatment must be delayed to prevent life-threatening neutropenia. Care should be taken when using this medication in cats, as they are sometimes more sensitive to the hematopoietic effects of platinum drugs compared to dogs.

Interactions

Carboplatin may exhibit additive nephrotoxicity if administered alongside aminoglycoside antibiotics (e.g., gentamicin or amikacin) or other potentially nephrotoxic medications. Because carboplatin can cause myelosuppression, concurrent use with other chemotherapy agents that cause bone marrow suppression—such as [Vinorelbine](/medications/vinorelbine-in-dogs-and-cats) or [Cytarabine](/medications/cytarabine-in-dogs-and-cats)—requires aggressive monitoring to ensure the patient does not develop dangerous hematological nadirs. There are no common interactions with typical maintenance medications like anti-epileptics or heart medications, but every drug the pet is currently taking must be disclosed to the veterinarian to avoid unforeseen cross-reactions.

Side Effects

Myelosuppression (low white blood cell counts)
Thrombocytopenia (low platelets)
Anemia
Gastrointestinal upset (vomiting, diarrhea, anorexia)
Lethargy
Nephrotoxicity (rare compared to other platinum agents)
Hypersensitivity reactions

Sources & References

Frequently Asked Questions

This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.

Find a Pharmacy